A USC study shows an improved version of CAR T-cell therapy seems to eliminate its serious side effects, which will make the treatment safer and potentially available in outpatient settings. Si – Yi Chen of the USC Norris Comprehensive Cancer Center, professor in the Department of Molecular Microbiology and Immunology at the Keck School of Medicine of USC, and senior author of the study said, “This is a major improvement”. He further added “We’ve made a new CAR molecule that’s just as efficient at killing cancer cells, but it works…
Read MoreImproved version in CAR T-cell therapy seems to eliminate its serious side effects
